Novartis top Japan executives quit over cancer drug scandal
The company also said it was freezing funding for clinical trials in the country in the wake of the scandal
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA finds contaminated drug ingredient at GSK Ireland plant
GSK said the ingredient was paroxetine, used to make its antidepressant drugs Paxil and Seroxat
Venus gets marketing nod from Venezuela for meropenem
Plans to launch the drug in the next couple of months
Glenmark’s NCE GRC 27864 for chronic inflammatory diseases to take part in human trials
GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1
Optel Vision to invest in pharmaceutical manufacturing industries
To expand distribution resources in Europe, Americas and Asia
Aurobindo completes acquisition of select Western European Businesses of Actavis
Actavis and Aurobindo have also entered into a long-term commercial and supply arrangement
Merck Sorono launches global initiative to improve patient outcomes in metastatic colorectal cancer
The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial…
April 1-15, 2014
{source}<div data-configid="5690019/7312757" style="width: 600px; height: 402px;" class="issuuembed"></div><script…
PARADIGM-HF trial of Novartis’ LCZ696 for chronic heart failure closes early based on strength…
Data Monitoring Committee (DMC) unanimously recommends early closure